Copyright
©The Author(s) 2024.
World J Clin Cases. Mar 6, 2024; 12(7): 1371-1377
Published online Mar 6, 2024. doi: 10.12998/wjcc.v12.i7.1371
Published online Mar 6, 2024. doi: 10.12998/wjcc.v12.i7.1371
Question | Yes | No | Don’t know | Patient’s score |
(1) Are there previous conclusive reports on this reaction? | +1 | 0 | 0 | +1 |
(2) Did the adverse event appear after the suspected drug was administered? | +2 | -1 | 0 | +2 |
(3) Did the adverse reaction improve when the drug was discontinued, or a specific antagonist was administered? | +1 | 0 | 0 | 0 |
(4) Did the adverse reaction reappear when the drug was re-administered? | +2 | -1 | 0 | 0 |
(5) Are there alternative causes (other than the drug) that could on their own have caused the reaction? | -1 | +2 | 0 | -1 |
(6) Did the reaction reappear when a placebo was given? | -1 | +1 | 0 | 0 |
(7) Was the drug detected in the blood (or other fluids) in concentrations known to be toxic? | +1 | 0 | 0 | 0 |
(8) Was the reaction more severe when the dose was increased, or less severe when the dose was decreased? | +1 | 0 | 0 | 0 |
(9) Did the patient have a similar reaction to the same or similar drug in any previous exposure? | +1 | 0 | 0 | 0 |
(10) Was the adverse event confirmed by any objective evidence? | +1 | 0 | 0 | +1 |
- Citation: Tan YW, Liu LP, Zhang K. Double plasma molecular adsorption system for Stevens–Johnson syndrome/toxic epidermal necrolysis: A case report. World J Clin Cases 2024; 12(7): 1371-1377
- URL: https://www.wjgnet.com/2307-8960/full/v12/i7/1371.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i7.1371